IDiyas

For the Inventor, By the Inventor

Plainsboro, NJ, United States of America

Hua Cheng

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 7.9

ph-index = 8

Forward Citations = 397(Granted Patents)


Company Filing History:

goldMedal9 out of 172 
 
Intra-cellular Therapies, Inc.
 patents

Years Active: 2012-2024

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents
1. 12139490 - Process for preparing 1-(4-fluorophenyl)-4-((6bR, 10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3',4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)butan-1-one (2024-11-12),
2. 11066407 - Preparation of certain substituted 1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalines and pharmaceutically acceptable salts thereof (2021-07-20),
3. 10597395 - Preparation of certain substituted 1-(4-fluorophenyl)-4-(2,3,6b,9,10,10a-hexahydro-1H-pyrido[3',4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-YL)butan-1-ones and pharmaceutically acceptable salts thereof (2020-03-24),
4. 10464938 - Pharmaceutical compositions comprising ((6bR,10aS)-1-(4-fluorophenyl)-4-(3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3',4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)butan-1-one or pharmaceutically acceptable salts thereof (2019-11-05),
5. 10221176 - Preparation of certain substituted [((6bR,10aS)-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3',4′:4,5]pyrrolo[1,2,3-de]quinoxalines and pharmaceutically acceptable salts thereof (2019-03-05),
6. 9751883 - Preparation of certain [((6BR,10AS)-2,3,6B,7,8,9,10, 10A-octahydro-1H-pyrido[3',4′:4,5]pyrrolo [1,2,3-de]quinoxalines and pharmaceutically acceptable salts thereof (2017-09-05),
7. 9315504 - Preparation of 4-((6BR,10AS)-3-methyl-2,3,6B,9,10, 10A-hexahydro-1H-pyrido[3',4′:4,5]pyrrolo [1,2,3-de]quinoxalin-8-(7H)-yl)-1-(4-fluorophenyl)-1-butanone or a pharmaceutically acceptable salt thereof (2016-04-19),
8. 8779139 - Substituted 2,3,4,4A,5,9B-hexahydro-1H-pyrido[4,3-B]indole derivatives synthesis and uses thereof (2014-07-15),
9. 8309722 - Substituted heterocycle gamma-carbolines synthesis (2012-11-13),

Title: Innovations by Inventor Hua Cheng in Pharmaceutical Chemistry

Introduction

Hua Cheng, based in Plainsboro, NJ, is a prominent inventor with a remarkable portfolio of nine patents. His contributions to the field of pharmaceutical chemistry are noteworthy, particularly in the development of novel compounds that hold significant therapeutic potential.

Latest Patents

Among Hua Cheng's latest patents is a process for preparing 1-(4-fluorophenyl)-4-((6bR, 10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3',4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)butan-1-one. This innovation outlines methods for synthesizing substituted heterocycle-fused gamma-carbolines, along with important intermediates useful for producing such compounds. Another significant patent focuses on the preparation of certain substituted 1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalines and their pharmaceutically acceptable salts, contributing to the advancement of medicinal chemistry.

Career Highlights

Hua Cheng has made substantial strides in the pharmaceutical industry through his work at Intra-Cellular Therapies, Inc. His expertise in synthesizing complex heterocycles has positioned him as a valuable asset in the quest for innovative treatments for various medical conditions.

Collaborations

Throughout his career, Hua Cheng has collaborated with several esteemed professionals, including John Charles Tomesch and Peng Li. These partnerships have fostered an environment of creativity and innovation, enabling the development of cutting-edge therapies.

Conclusion

Hua Cheng's extensive work and continued innovation in the field of pharmaceutical chemistry exemplify his commitment to improving health outcomes through scientific discovery. With a growing list of patents and a collaborative spirit, he remains a vital figure in the landscape of medical research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…